Treatment of BRAF inhibitor-induced hyperkeratosis.

Battley, Jodie E

Treatment of BRAF inhibitor-induced hyperkeratosis. [electronic resource] - Acta oncologica (Stockholm, Sweden) May 2013 - 874-7 p. digital

Publication Type: Case Reports; Letter

1651-226X

10.3109/0284186X.2012.716165 doi


Adult
Anti-Inflammatory Agents--therapeutic use
Antineoplastic Agents--adverse effects
Clobetasol--therapeutic use
Head and Neck Neoplasms--drug therapy
Humans
Imidazoles--adverse effects
Keratoderma, Palmoplantar--chemically induced
Male
Melanoma--drug therapy
Oximes--adverse effects
Protein Kinase Inhibitors--adverse effects
Proto-Oncogene Proteins B-raf--antagonists & inhibitors